Phreesia, Inc.

PHR

CIK 0001412408 · Quarterly mode · latest period FY2026 (Q4) (ending 2026-01-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q4)

Revenue
$127M
↑+15.9% +$17Mvs FY2025 (Q4)
Operating Income
$66M
↑+21.2% +$12Mvs FY2025 (Q4)
Net Income
$60M
↑+13.4% +$7Mvs FY2025 (Q4)
Gross Profit
$108M
↑+16.0% +$15Mvs FY2025 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Average
63/100
  • Profitability
    0ROIC -1.7% (10% = solid, 20%+ = moat)
  • Liquidity
    51Current Ratio 1.53 (above 1.5 = solid)
  • Leverage
    100D/E 0.01 (under 0.5 = conservative)
  • Efficiency
    55Asset Turnover 0.91x (1.0+ = capital-efficient)
  • Growth
    70Revenue YoY +15.9% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 3.1% · trend +16.0pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project PHR's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$18.94
Total enterprise IV
$1.16B
Diluted shares
0.06B
Terminal PV
$844M (72% of total)
Year-5 FCF
$99M
YearProjected FCFDiscounted PV
+1$73M$66M
+2$79M$65M
+3$85M$64M
+4$92M$63M
+5$99M$62M
Terminal$1.36B$844M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$11M
investment in PP&E
Stock buybacks (TTM)
share count reduction
Stock-based comp (TTM)
$67M
non-cash dilution

Balance sheet · 2026-01-31

latest filed snapshot
Total assets
$664M
everything owned
Total liabilities
$327M
everything owed
Stockholders' equity
$337M
shareholder claim
Net debt
$-71M
Net cash position ($71M)

Recent performance · 32 quarters

Revenue↑+15.9% +$17M
$127M
Net Income↑+129.7% +$19M
$4M
Free Cash Flow↑+131.0% +$18M
$31M
Operating Margin↑+16.1pts
3.1%

Drill down